These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8119308)

  • 21. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with levcromakalim, nilvadipine, and nifedipine.
    Izumi H; Jinno Y; Kaneta S; Tanaka Y; Okada Y; Izawa T; Ogawa N
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):189-97. PubMed ID: 7475042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intracoronary cromakalim, pinacidil, or diltiazem on cesium chloride-induced arrhythmias in anesthetized dogs under conditions of controlled coronary blood flow.
    D'Alonzo AJ; Hess TA; Darbenzio RB; Sewter JC
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):677-83. PubMed ID: 7681916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of torbafylline on blood flow, pO2 and function of rat ischaemic skeletal muscle.
    Okyayuz-Baklouti I
    Eur J Pharmacol; 1989 Jul; 166(1):75-86. PubMed ID: 2530093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Femoral vasodilation to cromakalim is blocked by U37883A, a non-sulphonylurea that selectively inhibits KATP channels.
    Lippton H; Choe E; Franklin E; Grivas T; Flint L; Hyman A; Ferrara J
    J Pharm Pharmacol; 1995 Mar; 47(3):243-5. PubMed ID: 7602489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
    Yamada H; Yoneyama F; Satoh K; Taira N
    Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
    Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K+ channel openers suppress myotonic activity of human skeletal muscle in vitro.
    Quasthoff S; Spuler A; Spittelmeister W; Lehmann-Horn F; Grafe P
    Eur J Pharmacol; 1990 Sep; 186(1):125-8. PubMed ID: 2282934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
    Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY
    Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog.
    D'Alonzo AJ; Darbenzio RB; Sewter JC; Hess TA; Grover GJ; Sleph PG; Normandin DE; Lodge NJ
    Eur J Pharmacol; 1995 Dec; 294(1):271-80. PubMed ID: 8788441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional hemodynamic dose-response of lemakalim and glybenclamide in anesthetized rats.
    Smits GJ; Perrone MH; Cox BF
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):49-56. PubMed ID: 9007670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ischaemic skeletal muscle hyperaemia in the anaesthetized cat: no contribution of A2A adenosine receptors.
    Poucher SM
    J Physiol; 1997 Apr; 500 ( Pt 1)(Pt 1):205-12. PubMed ID: 9097944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of intracavernous injection of potassium channel openers in monkeys and dogs.
    Trigo-Rocha F; Donatucci CF; Hsu GL; Nunes L; Lue TF; Tanagho EA
    Int J Impot Res; 1995 Mar; 7(1):41-8. PubMed ID: 7670592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Potassium agonists: regional vasodilator profile in rats].
    Richer C; Mulder P; Doussau MP; Giudicelli JF
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1333-7. PubMed ID: 2510669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats.
    Gardiner SM; Kemp PA; Bennett T
    Br J Pharmacol; 1991 Nov; 104(3):731-7. PubMed ID: 1797333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic and regional haemodynamic interactions between K+ channel openers and the sympathetic nervous system in the pithed SHR.
    Richer C; Mulder P; Doussau MP; Gautier P; Giudicelli JF
    Br J Pharmacol; 1990 Jul; 100(3):557-63. PubMed ID: 2390680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the haemodynamic profiles of Ro 31-6930, cromakalim and nifedipine in anaesthetised normotensive rats.
    Duty S; Paciorek PM; Waterfall JF; Weston AH
    Eur J Pharmacol; 1990 Aug; 185(1):35-42. PubMed ID: 2226633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism.
    Champion HC; Kadowitz PJ
    Am J Physiol; 1997 Jul; 273(1 Pt 2):R414-22. PubMed ID: 9249580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular pharmacology of SKP-450, a new potassium channel activator, and its major metabolites SKP-818 and SKP-310.
    Shin HS; Seo HW; Yoo SE; Lee BH
    Pharmacology; 1998 Mar; 56(3):111-24. PubMed ID: 9532610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.